{
    "organizations": [],
    "uuid": "81b0d1827b1d171a05b3554acf63c21058a9b636",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-phibro-animal-health-corp-reports/brief-phibro-animal-health-corp-reports-qtrly-diluted-eps-of-0-49-idUSFWN1SE0ZB",
    "ord_in_thread": 0,
    "title": "Phibro Animal Health Corp Reports Qtrly Diluted EPS Of $0.49",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Phibro Animal Health Corp:\n* ORATION REPORTS THIRD QUARTER * QTRLY NET SALES OF $209 MILLION, AN INCREASE OF $19 MILLION\n* QTRLY ADJUSTED DILUTED EPS OF $0.46 * Q3 EARNINGS PER SHARE VIEW $0.44 — THOMSON REUTERS I/B/E/S\n* CO IS NOT MODIFYING ITS FINANCIAL GUIDANCE FOR FISCAL YEAR 2018 AS PRESENTED IN CO’S FEBRUARY 5, 2018 PRESS RELEASE\n* FY2018 EARNINGS PER SHARE VIEW $1.69, REVENUE VIEW $810.9 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon:\nOur ",
    "published": "2018-05-08T04:48:00.000+03:00",
    "crawled": "2018-05-08T16:39:36.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "phibro",
        "animal",
        "health",
        "corp",
        "oration",
        "report",
        "third",
        "quarter",
        "qtrly",
        "net",
        "sale",
        "million",
        "increase",
        "million",
        "qtrly",
        "adjusted",
        "diluted",
        "eps",
        "q3",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "co",
        "modifying",
        "financial",
        "guidance",
        "fiscal",
        "year",
        "presented",
        "co",
        "february",
        "press",
        "release",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon"
    ]
}